Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology
To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine le...
Gespeichert in:
Veröffentlicht in: | The Journal of hospital infection 2006-05, Vol.63 (1), p.93-100 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 100 |
---|---|
container_issue | 1 |
container_start_page | 93 |
container_title | The Journal of hospital infection |
container_volume | 63 |
creator | Sax, H. Posfay-Barbe, K. Harbarth, S. Francois, P. Touveneau, S. Pessoa-Silva, C.L. Schrenzel, J. Dharan, S. Gervaix, A. Pittet, D. |
description | To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe. |
doi_str_mv | 10.1016/j.jhin.2005.11.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67889107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0195670106000053</els_id><sourcerecordid>67889107</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</originalsourceid><addsrcrecordid>eNqFkUurFDEQhYMo3vHqH3AhvdGVPabSNy9wI4MvuOBCXYd0utrJkE7GJC3MvzfDDNydroo6fFUcziHkJdAtUBDvDtvD3scto5RvAbZNekQ2wAfWMz3ox2RDQfNeSAo35FkpB0pp0_lTcgOC3zHJxYbsdynWnEKX5s52LqylYj4vLi3LGn099baU5LytOL3tFqx773wIPvYZiy_Vxtp9r_a4P4XkknNr6eyasQ0fu4gp2ppC-nV6Tp7MNhR8cZ235Oenjz92X_r7b5-_7j7c927QovZqgomPrllVfByUUgwnRtmsGRd6hJFr5uYJ3CD1zGepQDAcphFQW2WFFsMteXP5e8zp94qlmsUXhyHYZmYtRkilNFD5XxAkCKGkaiC7gC6nUjLO5pj9YvPJADXnIszBnIsw5yIMgGlSO3p1_b6OC04PJ9fkG_D6CtjibJizjc6XB07KOyaANe79hcMW2h-P2RTnMTqcfEZXzZT8v3z8BVsXqEo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17166878</pqid></control><display><type>article</type><title>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Sax, H. ; Posfay-Barbe, K. ; Harbarth, S. ; Francois, P. ; Touveneau, S. ; Pessoa-Silva, C.L. ; Schrenzel, J. ; Dharan, S. ; Gervaix, A. ; Pittet, D.</creator><creatorcontrib>Sax, H. ; Posfay-Barbe, K. ; Harbarth, S. ; Francois, P. ; Touveneau, S. ; Pessoa-Silva, C.L. ; Schrenzel, J. ; Dharan, S. ; Gervaix, A. ; Pittet, D.</creatorcontrib><description>To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/j.jhin.2005.11.016</identifier><identifier>PMID: 16542756</identifier><language>eng</language><publisher>Kent: Elsevier Ltd</publisher><subject>Adult ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial diseases ; Biological and medical sciences ; Community-Acquired Infections - microbiology ; Community-Acquired Infections - prevention & control ; Community-Acquired Infections - transmission ; Community-associated infections/microbiology/transmission ; Cross-infection/microbiology/transmission ; Disease Outbreaks ; Disease transmission, vertical ; Human bacterial diseases ; Humans ; Infant, Newborn ; Infection Control - methods ; Infectious diseases ; Intensive Care Units, Neonatal ; Medical sciences ; Methicillin Resistance ; Pharmacology. Drug treatments ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - transmission ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcal infections/microbiology/transmission ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation & purification ; Staphylococcus aureus - pathogenicity ; Switzerland - epidemiology</subject><ispartof>The Journal of hospital infection, 2006-05, Vol.63 (1), p.93-100</ispartof><rights>2006 The Hospital Infection Society</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</citedby><cites>FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhin.2005.11.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17742612$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16542756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sax, H.</creatorcontrib><creatorcontrib>Posfay-Barbe, K.</creatorcontrib><creatorcontrib>Harbarth, S.</creatorcontrib><creatorcontrib>Francois, P.</creatorcontrib><creatorcontrib>Touveneau, S.</creatorcontrib><creatorcontrib>Pessoa-Silva, C.L.</creatorcontrib><creatorcontrib>Schrenzel, J.</creatorcontrib><creatorcontrib>Dharan, S.</creatorcontrib><creatorcontrib>Gervaix, A.</creatorcontrib><creatorcontrib>Pittet, D.</creatorcontrib><title>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Community-Acquired Infections - prevention & control</subject><subject>Community-Acquired Infections - transmission</subject><subject>Community-associated infections/microbiology/transmission</subject><subject>Cross-infection/microbiology/transmission</subject><subject>Disease Outbreaks</subject><subject>Disease transmission, vertical</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infection Control - methods</subject><subject>Infectious diseases</subject><subject>Intensive Care Units, Neonatal</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Pharmacology. Drug treatments</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - transmission</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcal infections/microbiology/transmission</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Staphylococcus aureus - pathogenicity</subject><subject>Switzerland - epidemiology</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUurFDEQhYMo3vHqH3AhvdGVPabSNy9wI4MvuOBCXYd0utrJkE7GJC3MvzfDDNydroo6fFUcziHkJdAtUBDvDtvD3scto5RvAbZNekQ2wAfWMz3ox2RDQfNeSAo35FkpB0pp0_lTcgOC3zHJxYbsdynWnEKX5s52LqylYj4vLi3LGn099baU5LytOL3tFqx773wIPvYZiy_Vxtp9r_a4P4XkknNr6eyasQ0fu4gp2ppC-nV6Tp7MNhR8cZ235Oenjz92X_r7b5-_7j7c927QovZqgomPrllVfByUUgwnRtmsGRd6hJFr5uYJ3CD1zGepQDAcphFQW2WFFsMteXP5e8zp94qlmsUXhyHYZmYtRkilNFD5XxAkCKGkaiC7gC6nUjLO5pj9YvPJADXnIszBnIsw5yIMgGlSO3p1_b6OC04PJ9fkG_D6CtjibJizjc6XB07KOyaANe79hcMW2h-P2RTnMTqcfEZXzZT8v3z8BVsXqEo</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Sax, H.</creator><creator>Posfay-Barbe, K.</creator><creator>Harbarth, S.</creator><creator>Francois, P.</creator><creator>Touveneau, S.</creator><creator>Pessoa-Silva, C.L.</creator><creator>Schrenzel, J.</creator><creator>Dharan, S.</creator><creator>Gervaix, A.</creator><creator>Pittet, D.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7U2</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200605</creationdate><title>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</title><author>Sax, H. ; Posfay-Barbe, K. ; Harbarth, S. ; Francois, P. ; Touveneau, S. ; Pessoa-Silva, C.L. ; Schrenzel, J. ; Dharan, S. ; Gervaix, A. ; Pittet, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Community-Acquired Infections - prevention & control</topic><topic>Community-Acquired Infections - transmission</topic><topic>Community-associated infections/microbiology/transmission</topic><topic>Cross-infection/microbiology/transmission</topic><topic>Disease Outbreaks</topic><topic>Disease transmission, vertical</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infection Control - methods</topic><topic>Infectious diseases</topic><topic>Intensive Care Units, Neonatal</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Pharmacology. Drug treatments</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - transmission</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcal infections/microbiology/transmission</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Staphylococcus aureus - pathogenicity</topic><topic>Switzerland - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sax, H.</creatorcontrib><creatorcontrib>Posfay-Barbe, K.</creatorcontrib><creatorcontrib>Harbarth, S.</creatorcontrib><creatorcontrib>Francois, P.</creatorcontrib><creatorcontrib>Touveneau, S.</creatorcontrib><creatorcontrib>Pessoa-Silva, C.L.</creatorcontrib><creatorcontrib>Schrenzel, J.</creatorcontrib><creatorcontrib>Dharan, S.</creatorcontrib><creatorcontrib>Gervaix, A.</creatorcontrib><creatorcontrib>Pittet, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sax, H.</au><au>Posfay-Barbe, K.</au><au>Harbarth, S.</au><au>Francois, P.</au><au>Touveneau, S.</au><au>Pessoa-Silva, C.L.</au><au>Schrenzel, J.</au><au>Dharan, S.</au><au>Gervaix, A.</au><au>Pittet, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>2006-05</date><risdate>2006</risdate><volume>63</volume><issue>1</issue><spage>93</spage><epage>100</epage><pages>93-100</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe.</abstract><cop>Kent</cop><pub>Elsevier Ltd</pub><pmid>16542756</pmid><doi>10.1016/j.jhin.2005.11.016</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-6701 |
ispartof | The Journal of hospital infection, 2006-05, Vol.63 (1), p.93-100 |
issn | 0195-6701 1532-2939 |
language | eng |
recordid | cdi_proquest_miscellaneous_67889107 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adult Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial diseases Biological and medical sciences Community-Acquired Infections - microbiology Community-Acquired Infections - prevention & control Community-Acquired Infections - transmission Community-associated infections/microbiology/transmission Cross-infection/microbiology/transmission Disease Outbreaks Disease transmission, vertical Human bacterial diseases Humans Infant, Newborn Infection Control - methods Infectious diseases Intensive Care Units, Neonatal Medical sciences Methicillin Resistance Pharmacology. Drug treatments Staphylococcal Infections - drug therapy Staphylococcal Infections - epidemiology Staphylococcal Infections - transmission Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcal infections/microbiology/transmission Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - isolation & purification Staphylococcus aureus - pathogenicity Switzerland - epidemiology |
title | Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A27%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20a%20cluster%20of%20community-associated,%20methicillin-resistant%20Staphylococcus%20aureus%20in%20neonatology&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Sax,%20H.&rft.date=2006-05&rft.volume=63&rft.issue=1&rft.spage=93&rft.epage=100&rft.pages=93-100&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/j.jhin.2005.11.016&rft_dat=%3Cproquest_cross%3E67889107%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17166878&rft_id=info:pmid/16542756&rft_els_id=S0195670106000053&rfr_iscdi=true |